PSPH and acute lymphoblastic leukemia: Although the mechanisms that render T-ALL cells vulnerable to inhibition of this pathway are still unknown, these results demonstrate that the targeting of PSPH may serve as a novel therapeutic approach for a subgroup of T-ALL patients [76].